Pathway Financial Advisers, LLC Cellebrite Di Ltd. Transaction History
Pathway Financial Advisers, LLC
- $292 Million
- Q4 2024
A detailed history of Pathway Financial Advisers, LLC transactions in Cellebrite Di Ltd. stock. As of the latest transaction made, Pathway Financial Advisers, LLC holds 260 shares of CLBT stock, worth $6,760. This represents 0.0% of its overall portfolio holdings.
Number of Shares
260
Previous 4,378
94.06%
Holding current value
$6,760
Previous $260,000
98.08%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CLBT
# of Institutions
183Shares Held
88.3MCall Options Held
741KPut Options Held
205K-
True Wind Capital Management, L.P.13.9MShares$360 Million87.15% of portfolio
-
Morgan Stanley New York, NY5.38MShares$140 Million0.01% of portfolio
-
Acadian Asset Management LLC Boston, MA4.39MShares$114 Million0.23% of portfolio
-
Nine Ten Capital Management LLC Evanston, IL4.33MShares$112 Million22.02% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L33.5MShares$90.9 Million0.69% of portfolio
About Cellebrite DI Ltd.
- Ticker CLBT
- Exchange NASDAQ
- Sector Technology
- Industry Software—Infrastructure
- Shares Outstandng 189,648,992
- Market Cap $4.93B
- Description
- Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border c...